Details
Most older adults with transthyretin cardiac amyloidosis (ATTR-CM) experienced at least 6 months of delay in diagnosis after a first heart failure (HF) diagnosis. Those delays did not improve over time. Women and patients with certain comorbidities were more likely to experience a delayed diagnosis